A total of 1,162 eligible individuals received the second vaccination dose against meningococcal-B on Monday, according to University Spokesperson Martin Mbugua. An additional 305 individuals received the second dose last month, which included some student athletes as well as students who were going abroad for the semester.
The running total of 1,467 vaccinations represents a 25 percent decrease from the 1,959 vaccines administered on the first day of vaccinations for the initial dosage, which was offered to students in December.
The first dose has been received by 5,382 individuals so far, and the second dose will continue to be administered from noon to 8 p.m. in the basement of Frist Campus Center until Thursday evening.
Eligible vaccine candidates are limited to undergraduates, graduate students living in dormitories and University community members with certain medical conditions.
The vaccine, which is not currently approved for use in the United States, is being offered in an effort to curb an outbreak of meningitis type B that has affected 8 students and a campus visitor since March. The last case was of the disease was reported in December, just a few weeks before the first dose of the vaccine was offered.